KENALOG Safety Questions, KENALOG Answers


More Here>>Side Effects - FDA Reports 2006-2008

Medications A-Z:   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Welcome! Patientsville.com provides unique information about KENALOG. Our extensive database of KENALOG adverse events and KENALOG warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.

>> Announcements
Check out our Hospital and Home Care Quality Reports.

Ask Our Health Experts about KENALOG

Do You Have a Question about Your Health?

Our Doctors and Nurses will Help You Understand Your Symptoms and Feel Better!
Private, Confidential and Discreet



KENALOG Safety Reports

Total KENALOG reports: 145.
KENALOG FDA safety alerts: No.
Reported deaths: 2    Reported hospitalizations: 21.
Take KENALOG Side Effects Survey or Share Your KENALOG Story. KENALOG Usage.

Showing 1-75 of 145 Next >

Physician from UNITED STATES reported KENALOG problem on June 30, 2006. Male patient, 68 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: eye inflammation. KENALOG dosage: unknown. Patient was hospitalized. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED STATES on May 02, 2006. Male patient, 85 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: eye inflammation. KENALOG dosage: unknown. During the same period patient was treated with TOPROL, HYDROCHLOROTHIAZIDE, MONOPRIL, TRENTAL, ZOCOR, XANAX, OMEPRAZOLE. Patient recovered.

Health Professional from UNITED STATES reported KENALOG problem on May 09, 2006. Female patient, 55 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis, hypopyon. KENALOG dosage: unknown. During the same period patient was treated with FLOVENT, PROVENTIL, COZAAR. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED KINGDOM on Aug 16, 2006. Female patient, 22 years of age, weighting 132.3 lb, was diagnosed with seasonal allergy and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site scar. KENALOG dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported KENALOG problem on Aug 17, 2006. Female patient, child 8 years of age, was diagnosed with juvenile arthritis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: skin striae. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED KINGDOM on Aug 23, 2006. Male patient, 60 years of age, weighting 284.4 lb, was diagnosed with osteoarthritis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: chest discomfort, dyspnoea, throat tightness, vomiting. KENALOG dosage: unknown. During the same period patient was treated with LIDOCAINE, ASPIRIN, BEZAFIBRATE, BISOPROLOL FUMARATE, DICLOFENAC, GABAPENTIN, ISOSORBIDE MONONITRATE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Aug 24, 2006. Female patient, 30 years of age, weighting 112.4 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, gastroenteritis viral, laryngitis, sinusitis, uterine haemorrhage. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 19, 2006. Female patient, 21 years of age, weighting 340.0 lb, was diagnosed with hypersensitivity, nasal mucosal disorder and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: back pain, depression, dysmenorrhoea, insomnia, poor quality sleep, vulvovaginal mycotic infection. KENALOG dosage: 40MG ONCE SUBDERMAL. Patient recovered.

Physician from IRELAND reported KENALOG problem on Sept 01, 2006. Female patient, 20 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: fat necrosis. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Female patient was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Sept 18, 2006. Male patient was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Female patient was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported KENALOG problem on Sept 26, 2006. Male patient, 42 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site pain. KENALOG dosage: unknown. Patient was hospitalized. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Male patient, 56 years of age, was diagnosed with macular oedema, diabetic retinopathy and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: vision blurred. KENALOG dosage: unknown. During the same period patient was treated with VIGAMOX, PROPARACAINE, BETADINE, BYETTA, INSULIN, METOPROLOL TARTRATE, LIPITOR. Patient recovered.

Health Professional from UNITED STATES reported KENALOG problem on Aug 03, 2006. Male patient, 74 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. During the same period patient was treated with AVANDIA, AGGRENOX, RAZADYNE, FEOSOL, ASPIRIN, LIPITOR, ZYMAR. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED STATES on Aug 03, 2006. Male patient, 78 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: vision blurred. KENALOG dosage: unknown. During the same period patient was treated with ZYMAR. Patient recovered.

Health Professional from UNITED STATES reported KENALOG problem on Aug 03, 2006. Male patient, 75 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: eye inflammation. KENALOG dosage: unknown. During the same period patient was treated with QUINIDINE SULPHATE, LIPITOR, ASPIRIN, ECONOPRED, NEVANAC. Patient recovered.

KENALOG problem was reported by a Physician from UNITED STATES on July 10, 2006. Male patient, 91 years of age, was diagnosed with hypothyroidism and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis, intraocular pressure increased, vitreous opacities. KENALOG dosage: unknown. During the same period patient was treated with SYNTHROID. Patient recovered.

Health Professional from UNITED STATES reported KENALOG problem on July 10, 2006. Female patient, child 10 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. During the same period patient was treated with ALTACE, ACTONEL, ATENOLOL, SLOW FE, TYLENOL, ACIDOPHILUS, MUCINEX, SALINEX. Patient was hospitalized. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED STATES on July 10, 2006. Female patient, 57 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. During the same period patient was treated with ESTROGENS SOL. Patient recovered.

Physician from UNITED STATES reported KENALOG problem on July 10, 2006. Female patient, 74 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. During the same period patient was treated with OMEGA, ESTER, VITAMIN D, CALCIUM. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2006. Female patient, 86 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. During the same period patient was treated with MYDRIACYL, NEO SYNEPHRINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Sept 18, 2006. Female patient, 87 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. During the same period patient was treated with VIGAMOX. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 19, 2006. Female patient, 30 years of age, weighting 138.9 lb, was diagnosed with myalgia and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: body temperature increased, dizziness, flushing, gastrooesophageal reflux disease, injection site atrophy, nausea, vision blurred, weight decreased. KENALOG dosage: unknown. Patient was hospitalized. Patient recovered.

Consumer or non-health professional from UNITED KINGDOM reported KENALOG problem on Sept 27, 2006. Female patient, 45 years of age, was diagnosed with eczema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site abscess. KENALOG dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, VENTOLIN, SERETIDE, MONTELUKAST, CHLORPHENIRAMINE MALEATE. Patient was hospitalized. Patient recovered.

KENALOG problem was reported by a Physician from UNITED STATES on July 12, 2005. Female patient, 77 years of age, weighting 119.0 lb, was diagnosed with pain and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: ecchymosis, skin atrophy, skin haemorrhage. KENALOG dosage: unknown. During the same period patient was treated with ACTONEL. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Sept 08, 2005. Female patient, 52 years of age, was diagnosed with tendonitis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: blood glucose increased. KENALOG dosage: unknown. During the same period patient was treated with NPH INSULIN, HUMULIN R, TIMOLOL MALEATE. Patient recovered.

KENALOG problem was reported by a Physician from UNITED STATES on Sept 26, 2005. Female patient, 70 years of age, weighting 189.6 lb, was diagnosed with back pain, sciatica, spinal column stenosis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: alopecia. KENALOG dosage: unknown. During the same period patient was treated with SYNTHROID. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Oct 10, 2005. Female patient, 59 years of age, weighting 138.9 lb, was diagnosed with sinusitis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: dysgeusia. KENALOG dosage: unknown. During the same period patient was treated with PREDNISONE, ARMOUR THYROID, ESTRACE, OXAZEPAM, HYDROCHLOROTHIAZIDE DIURETIC, PREMARIN. Patient recovered.

KENALOG problem was reported by a Physician from UNITED STATES on Nov 15, 2005. Female patient, 78 years of age, weighting 200.6 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: flushing, intraocular pressure increased, vision blurred, visual acuity reduced. KENALOG dosage: unknown. During the same period patient was treated with METHOTREXATE, PREDNISONE. Patient recovered.

Physician from UNITED STATES reported KENALOG problem on Nov 15, 2005. Female patient, 46 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: atrophy, injection site pain. KENALOG dosage: unknown. During the same period patient was treated with PERCOCET, EVISTA, EFFEXOR. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2005. Female patient, 31 years of age, weighting 154.3 lb, was diagnosed with intervertebral disc protrusion and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: hypoaesthesia, pain, visual disturbance. KENALOG dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Feb 14, 2006. Female patient, 60 years of age, weighting 134.5 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: erythema, injection site pruritus. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 15, 2006. Female patient, 28 years of age, weighting 119.0 lb, was diagnosed with sinusitis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site nerve damage, injection site pain, muscle atrophy. KENALOG dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Apr 05, 2006. Female patient, 32 years of age, weighting 138.9 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, skin hypopigmentation. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED STATES on May 02, 2006. Male patient, 51 years of age, was diagnosed with diabetic retinal oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: eye inflammation. KENALOG dosage: unknown. During the same period patient was treated with NEURONTIN, EPOGEN, PHOSLO, ALPHAGAN, PRAVACHOL, LASIX, ELAVIL, METOLAZONE. Patient recovered.

Physician from UNITED STATES reported KENALOG problem on May 17, 2006. Female patient, 54 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: vaginal haemorrhage. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED STATES on May 02, 2006. Male patient, 73 years of age, was diagnosed with diabetic retinal oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: eye inflammation, vision blurred. KENALOG dosage: unknown. During the same period patient was treated with NPH INSULIN, ASPIRIN. Patient recovered.

Health Professional from UNITED STATES reported KENALOG problem on May 02, 2006. Male patient, 51 years of age, was diagnosed with retinopathy and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: eye inflammation. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED STATES on May 02, 2006. Female patient, 81 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: eye inflammation, hypopyon, visual disturbance. KENALOG dosage: unknown. During the same period patient was treated with LEVOXYL, PREMARIN, LANOXIN, LIPITOR, WARFARIN, CALCIUM GLUCONATE. Patient recovered.

Physician from UNITED STATES reported KENALOG problem on June 01, 2006. Female patient, 85 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: eye infection. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 10, 2006. Female patient was diagnosed with arthritis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site irritation. KENALOG dosage: unknown. During the same period patient was treated with LIDOCAINE, CARBOCAINE, BUPIVACAINE. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Aug 15, 2006. Male patient, child 4 years of age, was diagnosed with hypersensitivity and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, skin discolouration. KENALOG dosage: unknown. During the same period patient was treated with AMOXICILLIN. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2006. Male patient, 43 years of age, weighting 165.3 lb, was diagnosed with pain management and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: hyperhidrosis, impaired healing, increased tendency to bruise, skin atrophy. KENALOG dosage: KENALOG-40 INJ, 80MG ON 14-MAR-2006, 28-MAR-2006, 11-APR-2006.. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Sept 18, 2006. Male patient, 62 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: unknown. During the same period patient was treated with VANCOCIN, CEFTAZIDIME. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 26, 2006. Male patient, 50 years of age, weighting 180.8 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site pain. KENALOG dosage: unknown. Patient was hospitalized. Patient recovered.

Health Professional from UNITED KINGDOM reported KENALOG problem on Oct 30, 2006. Male patient, 59 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: glaucoma. KENALOG dosage: unknown. Patient recovered.

KENALOG problem was reported by a Physician from IRELAND on Sept 01, 2006. Female patient, 20 years of age, weighting 125.7 lb, was diagnosed with seasonal allergy and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: fat necrosis, injection site fibrosis. KENALOG dosage: unknown. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on Nov 07, 2006. Female patient, 75 years of age, was diagnosed with neck pain and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: breast swelling. KENALOG dosage: unknown. Patient was hospitalized. Patient recovered.

KENALOG problem was reported by a Physician from IRELAND on Sept 01, 2006. Female patient, 20 years of age, weighting 125.7 lb, was diagnosed with seasonal allergy and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: injection site fibrosis. KENALOG dosage: unknown. Patient recovered.

Physician from UNITED STATES reported KENALOG problem on Sept 27, 2006. Female patient, 68 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: endophthalmitis. KENALOG dosage: 4 MG IN 0.1 CC. During the same period patient was treated with INSULIN, PRINIVIL, ZOCOR, ASPIRIN, XANAX, ULTRAM, SYNTHROID, NEXIUM. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 27, 2006. Female patient, 41 years of age, was diagnosed with macular oedema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: alpha haemolytic streptococcal infection, endophthalmitis. KENALOG dosage: unknown. During the same period patient was treated with COSOPT, PREDTE. Patient recovered.

Health Professional from UNITED KINGDOM reported KENALOG problem on Nov 20, 2006. Female patient, 38 years of age, weighting 136.7 lb, was diagnosed with inflammation, local anaesthesia and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: dyspepsia, erythema, food craving, hot flush, joint swelling, pain in extremity. KENALOG dosage: unknown. During the same period patient was treated with BUPIVACAINE. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 20, 2006. Female patient, 32 years of age, weighting 140.0 lb, was diagnosed with haemorrhoids and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: acne, injection site atrophy, menorrhagia, ulcer. KENALOG dosage: unknown. Patient recovered.

Health Professional from UNITED KINGDOM reported KENALOG problem on Mar 24, 2006. Male patient, 60 years of age, was diagnosed with plantar fasciitis, irritable bowel syndrome, constipation, gastrooesophageal reflux disease, benign prostatic hyperplasia and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: choking, circulatory collapse, paraesthesia. KENALOG dosage: unknown. During the same period patient was treated with LIDOCAINE, ALVERINE CITRATE, ISPAGHULA, OMEPRAZOLE, TAMSULOSIN. Patient died on 12/06/2005.

KENALOG problem was reported by a Physician from UNITED KINGDOM on Feb 17, 2006. Male patient, 55 years of age, weighting 187.4 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: extravasation, monoplegia. KENALOG dosage: unknown. During the same period patient was treated with MARCAINE. Patient was hospitalized and became disabled. Patient recovered.

Health Professional from UNITED KINGDOM reported KENALOG problem on Mar 24, 2006. Female patient, child 8 years of age, weighting 74.96 lb, was diagnosed with juvenile arthritis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: cushingoid, weight increased. KENALOG dosage: unknown. During the same period patient was treated with IBUPROFEN. Patient recovered.

KENALOG problem was reported by a Physician from UNITED STATES on Oct 05, 2006. Female patient, 20 years of age, was diagnosed with prophylaxis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: cushing's syndrome, pruritus. KENALOG dosage: unknown. During the same period patient was treated with VICODIN. Patient recovered.

Health Professional from UNITED KINGDOM reported KENALOG problem on Dec 23, 2004. Female patient, weighting 114.6 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: necrotising scleritis. KENALOG dosage: unknown. During the same period patient was treated with FOSAMAX, ACETAMINOPHEN W, ERGOCALCIFEROL, VISUDYNE. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED STATES on Dec 14, 2006. Male patient was diagnosed with diabetic retinopathy, macular oedema, retinal neovascularisation and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: visual acuity reduced. KENALOG dosage: 4 MG / 0.1ML 1 TIME INTRAOCULAR. Patient recovered.

Consumer or non-health professional from UNITED STATES reported KENALOG problem on June 06, 2006. Female patient, 80 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: alopecia, hyperhidrosis. KENALOG dosage: unknown. During the same period patient was treated with FENTANYL TRANSDERMAL SYSTEM. Patient recovered.

KENALOG problem was reported by a Health Professional from UNITED KINGDOM on July 09, 2007. Female patient, 64 years of age, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: chest discomfort, pruritus. KENALOG dosage: unknown. During the same period patient was treated with LIDOCAINE, CODEINE PHOSPHATE AND ACETAMINOPHEN, PARACETAMOL. Patient was hospitalized. Patient recovered.

Health Professional from SWEDEN reported KENALOG problem on Aug 03, 2007. Female patient, 35 years of age, was diagnosed with rheumatoid arthritis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, hypersensitivity, joint swelling, pruritus, rash macular, urticaria. KENALOG dosage: unknown. During the same period patient was treated with RIDAURA, VOLTAREN, XYLOCAINE. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Female patient, 29 years of age, weighting 138.9 lb, was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: alopecia, contusion, feeling cold, gastrointestinal haemorrhage, injection site atrophy, mood altered, pain, rash papular, skin exfoliation. KENALOG dosage: 1 FORM= 40 MG/ML(2 ML UNDILUTED).. During the same period patient was treated with PRENATAL VITAMINS. Patient was hospitalized. Patient recovered.

Health Professional from UNITED STATES reported KENALOG problem on Aug 27, 2007. Female patient, 29 years of age, weighting 138.0 lb, was diagnosed with keloid scar and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: alopecia, amenorrhoea, arthralgia, back pain, breast feeding, contusion, decreased activity, fibrosis, frustration. KENALOG dosage: 2 ML ONCE INTRA-ARTIC. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient, weighting 123.0 lb, was diagnosed with eczema and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: atrophy, back pain, headache, menorrhagia, pain in extremity, skin striae. KENALOG dosage: unknown. Patient recovered.

Physician from UNITED STATES reported KENALOG problem on Sept 06, 2007. Female patient, 44 years of age, weighting 134.0 lb, was diagnosed with rhinitis allergic and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: migraine, polymenorrhoea. KENALOG dosage: 80MG ONCE IM. Patient recovered.

KENALOG problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 18, 2007. Female patient, weighting 116.0 lb, was diagnosed with urticaria and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: anxiety, menorrhagia, menstruation irregular, polymenorrhoea. KENALOG dosage: unknown. Patient recovered.

Consumer or non-health professional from SWEDEN reported KENALOG problem on Sept 18, 2007. Female patient, 35 years of age, was diagnosed with rheumatoid arthritis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock. KENALOG dosage: unknown. During the same period patient was treated with XYLOCAINE. Patient was hospitalized. Patient recovered.

KENALOG problem was reported by a Health Professional from IRELAND on Sept 18, 2007. Female patient, 35 years of age, was diagnosed with rheumatoid arthritis and was treated with KENALOG. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, hypersensitivity, joint swelling, pruritus, rash macular, urticaria. KENALOG dosage: unknown. During the same period patient was treated with RIDAURA, VOLTAREN, XYLOCAINE. Patient recovered.

Showing 1-75 of 145 Next >

Ask Our Patient Community about KENALOG

Select a Medication and Click to Access Reports about Side Effects and Adverse Reactions

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z
This drug has as active FDA Safety Alert This drug has an active FDA Safety Alert
A
Abacavir sulfate
Abatacept
Abilify
Acamprosate calcium
AccuprilThis drug has as active FDA Safety Alert
AccutaneThis drug has as active FDA Safety Alert
AceonThis drug has as active FDA Safety Alert
Aciphex
Actiq (fentanyl citrate)
ActimmuneThis drug has as active FDA Safety Alert (aripiprazole) (quinapril) (isotretinoin) (perindopril) (rabeprazole) (interferon gamma-1b)
ActonelThis drug has as active FDA Safety Alert (risedronate)
Actoplus MetThis drug has as active FDA Safety Alert (pioglitazone)
ActosThis drug has as active FDA Safety Alert (pioglitazone)
AcuTect (technetium Tc 99m apcitide)
Adefovir dipivoxil
Advair Diskus(Fluticasone propionate; Salmeterol xinafoate)
AdderallThis drug has as active FDA Safety Alert (amphetamine salts)
Agenerase (amprenavir)
Aggrastat (tirofiban)
Alamast (pemirolast)
AlendronateThis drug has as active FDA Safety Alert
AlemtuzumabThis drug has as active FDA Safety Alert
AleveThis drug has as active FDA Safety Alert (naproxen sodium)
Alfuzosin
Alinia (nitazoxanide)
Alimta (pemetrexed)
Alitretinoin
Almotriptan malateThis drug has as active FDA Safety Alert
Alosetron hydrochloride
Aloxi (palonosetron)
Alrex (loteprednol etabonate)
AltaceThis drug has as active FDA Safety Alert (ramipril)
Ambien (zolpidem tartrate)
AmergeThis drug has as active FDA Safety Alert (naratriptan)
Aminolevulinic acid
AmiodaroneThis drug has as active FDA Safety Alert
Amitiza (lubiprostone)
AmnesteemThis drug has as active FDA Safety Alert (isotretinoin)
Amphadase (hyaluronidase)
luronidase)
Amphetamine saltsThis drug has as active FDA Safety Alert
Amprenavir
AnaproxThis drug has as active FDA Safety Alert (naproxen sodium)
Angiomax (bivalirudin)
Anidulafungin
Antagon (ganirelix acetate)
Anthelios SX (avobenzone, ecamsule, octocrylene)
Apidra (insulin glulisine recombinant)
Apokyn (apomorphine)
Aprepitant
Aprotinin
Aptivus (tipranavir)
AranespThis drug has as active FDA Safety Alert (darbepoetin alpha)
Arava (leflunomide)
Arformoterol
Argatroban
ArediaThis drug has as active FDA Safety Alert (pamidronate)
Aripiprazole
Arixtra (fondaparinux)
Aromasin (exemestane)
Arranon (nelarabine)
Arsenic trioxide
Aspirin
Atacand (candesartan cilexetil)
Atazanavir sulfate
AtomoxetineThis drug has as active FDA Safety Alert
Avastin (bevacizumab)
Avelox (moxifloxacin)
Avobenzone, Ecamsule, Octocrylene
Avodart (dutasteride)
Avonex (interferon beta-1a)
AxertThis drug has as active FDA Safety Alert (almotriptan malate)
Azacitidine
Azilect (rasagiline)
Azopt (brinzolamide)

back to top

B
Balsalazide disodium
Baraclude (entecavir)
BenazeprilThis drug has as active FDA Safety Alert
Benicar (olmesartan medoxomil)
Bevacizumab
Bexarotene
BextraThis drug has as active FDA Safety Alert (valdecoxib)
BiaxinThis drug has as active FDA Safety Alert (clarithromycin)
Bimatoprost
Bivalirudin
BonivaThis drug has as active FDA Safety Alert (ibandronate)
Bortezomib
Brinzolamide
Brovana (arformoterol)
BupropionThis drug has as active FDA Safety Alert
Butisol sodium
Byetta (exenatide)


back to top

C
Calfactant
CampathThis drug has as active FDA Safety Alert (alemtuzumab)
Campral (acamprosate calcium)
Cancidas (caspofungin)
Candesartan cilexetil
Capecitabine
CapotenThis drug has as active FDA Safety Alert (captopril)
CaptoprilThis drug has as active FDA Safety Alert
CarbamazepineThis drug has as active FDA Safety Alert
CarbatrolThis drug has as active FDA Safety Alert (carbamazepine)
Carbrital (pentobarbital and carbromal)
Caspofungin
Cefditoren pivoxil
CefepimeThis drug has as active FDA Safety Alert
CeftriaxoneThis drug has as active FDA Safety Alert
CelebrexThis drug has as active FDA Safety Alert (celecoxib)
CelecoxibThis drug has as active FDA Safety Alert
CelexaThis drug has as active FDA Safety Alert (citalopram hydrobromide)
Cetrorelix acetate
Cetrotide (cetrorelix acetate)
Cetuximab
Cevimeline
ChantixThis drug has as active FDA Safety Alert (varenicline)
Cialis (tadalafil)
Cilostazol
Cinacalcet
Cirlesonide
CitalopramThis drug has as active FDA Safety Alert
ClaravisThis drug has as active FDA Safety Alert (isotretinoin)
ClarithromycinThis drug has as active FDA Safety Alert
Clarinex (desloratadine)
Clolar (clofarabine)
Clofarabine
Clozapine
Clozaril (clozapine)
CodeineThis drug has as active FDA Safety Alert
Colazal (balsalazide disodium)
Colesevelam
ColistimethateThis drug has as active FDA Safety Alert
Coly-Mycin M (colistimethate)This drug has as active FDA Safety Alert
Comtan (entacapone)
Concerta (methylphenidate)
Conivaptan
CordaroneThis drug has as active FDA Safety Alert (amiodarone)
CrestorThis drug has as active FDA Safety Alert (rosuvastatin calcium)
Cubicin (daptomycin)
Curosurf (poractant alfa)
CylertThis drug has as active FDA Safety Alert (pemoline)
CymbaltaThis drug has as active FDA Safety Alert (duloxetine)
CytotecThis drug has as active FDA Safety Alert (misoprostol)

back to top

D
Dacogen (decitabine)
Dalfopristin
Dalmane (flurazepam)
Daptomycin
Darbepoetin alphaThis drug has as active FDA Safety Alert
Darifenacin
Darunavir
Dasatinib
Daytrana (methylphenidate transdermal)
DDAVPThis drug has as active FDA Safety Alert (desmopressin)
DDAVP Nasal SprayThis drug has as active FDA Safety Alert (demopressin)
DDAVP Rhinal TubeThis drug has as active FDA Safety Alert (desmopressin)
DDVPThis drug has as active FDA Safety Alert (desmopressin
Decitabine
Deferasirox
Definity (perflutren lipid microspheres)
DepaconThis drug has as active FDA Safety Alert (valproate)
DepakeneThis drug has as active FDA Safety Alert (valproate)
DepakoteThis drug has as active FDA Safety Alert (valproate)
Desloratadine
DesmopressinThis drug has as active FDA Safety Alert
Detrol (tolterodine tartrate)
terodine tartrate)
Dexedrine (dextroamphetamine sulfate)
Dexmedetomidine
Dexmethylphenidate HCl
> Dextroamphetamine sulfate
Diastat AcuDialThis drug has as active FDA Safety Alert
Diazepam rectal gelThis drug has as active FDA Safety Alert
DidronelThis drug has as active FDA Safety Alert (etidronate)
DiprivanThis drug has as active FDA Safety Alert (propofol)
Dofetilide
Doral (quazepam)
Doxercalcif
Drospirenone
DuloxetineThis drug has as active FDA Safety Alert
DuragesicThis drug has as active FDA Safety Alert (fentanyl transdermal system)
Dutasteride

back to top

E

Eculizumab
Edetate disodium
Efalizumab
Efavirenz
EffexorThis drug has as active FDA Safety Alert (venlafaxine)
Elestat (epinastine)
EletriptanThis drug has as active FDA Safety Alert
Elidel (pimecrolimus)
Ellence (epirubicin)
Eloxatin (oxaliplatin)
Emend (aprepitant)
Emtricitabine
Emtriva (emtricitabine)
Enablex (darifenacin)
Enalapril / EnalaprilatThis drug has as active FDA Safety Alert
Endrate (edetate disodium)
Enfuvirtide
Entacapone
Entecavir
Epinastine
Epirubicin
Eplerenone
Epoetin alfaThis drug has as active FDA Safety Alert
EpogenThis drug has as active FDA Safety Alert (epoetin alfa)
Eptifibatide
EquetroThis drug has as active FDA Safety Alert (carbamazepine)
Eraxis (anidulafungin)
Erbitux (cetuximab)
Ertaczo (sertaconazole)
EscitalopramThis drug has as active FDA Safety Alert
Estazolam
Eszopiclone
Ethchlorvynol
Ethinyl estradiol
EtidronateThis drug has as active FDA Safety Alert
Evoxac (cevimeline)
Exelon (rivastigmine tartrate)
Exenatide
Exjade (deferasirox)
Exemestane
Extraneal (icodextrin)
Ezetimibe
Ezetimibe/simvastatin

back to top

 F
Factive (gemifloxacin mesylate)
Faslodex (fulvestrant)
FelbamateThis drug has as active FDA Safety Alert
FelbatolThis drug has as active FDA Safety Alert (felbamate)
Fentanyl buccal tabletsThis drug has as active FDA Safety Alert
Fentanyl citrate
Fentanyl transdermal systemThis drug has as active FDA Safety Alert
FentoraThis drug has as active FDA Safety Alert (fentanyl buccal tablets)
Ferrlecit (sodium ferric gluconate complex)
Fleet Accu-PrepThis drug has as active FDA Safety Alert (sodium phosphate)
Fleet Phospho-SodaThis drug has as active FDA Safety Alert (sodium phosphate)
FluoxetineThis drug has as active FDA Safety Alert
Flurazepam
Fluticasone propionate
FluvoxamineThis drug has as active FDA Safety Alert
Focalin (dexmethylphenidate)
Focalin XR (dexmethylphenidate)
Fomivirsen
Fondaparinux
Foradil (formoterol fumarate)
Formoterol fumarate
FosamaxThis drug has as active FDA Safety Alert (alendronate)
FosinoprilThis drug has as active FDA Safety Alert
FrovaThis drug has as active FDA Safety Alert (frovatriptan succinate)
Frovatriptan succinateThis drug has as active FDA Safety Alert
Fulvestrant
Fuzeon (enfuvirtide)

G
GabapentinThis drug has as active FDA Safety Alert
GabitrilThis drug has as active FDA Safety Alert (tiagabine)
Gadobenate DimeglumineThis drug has as active FDA Safety Alert
GadodiamideThis drug has as active FDA Safety Alert
GadoliniumThis drug has as active FDA Safety Alert
Gadopentetate DimeglumineThis drug has as active FDA Safety Alert
GadoteridolThis drug has as active FDA Safety Alert
GadoversetamideThis drug has as active FDA Safety Alert
GalantamineThis drug has as active FDA Safety Alert
Ganirelix acetate
GatifloxacinThis drug has as active FDA Safety Alert
GefitinibThis drug has as active FDA Safety Alert
Gemifloxacin mesylate
Gemtuzumab ozogamicin
Geodon (ziprasidone)
Gleevec (imatinib mesylate)

back to top

H
Halcion (triazolam)
HaldolThis drug has as active FDA Safety Alert (haloperidol)
HaloperidolThis drug has as active FDA Safety Alert
Hectorol (doxercalcif)
Hepsera (adefovir dipivoxil)
Hyaluronidase
Hydase (hyaluronidase)
Human Secretin

back to top

I
IbandronateThis drug has as active FDA Safety Alert
Ibuprofen
Icodextrin
Iloprost
Imatinib mesylate
Increlex (Mecasermin [rDNA origin]
Infasurf Preservative Free (calfactant)
ImitrexThis drug has as active FDA Safety Alert (sumatriptan)
Innohep (tinzaparin)
Inspra (eplerenone)
Insulin Aspart recombinant
Insulin Detemir recombinant
Insulin Glargine recombinant
Insulin Glulisine recombinant
Intron A (interferon alfa-2b)
Integrilin (eptifibatide)
ifibatide)
Interferon alfa-2b
Interferon beta-1a
Interferon gamma-1bThis drug has as active FDA Safety Alert
Invega (paliperidone)
Iplex  (mecasermin rinfabate)
IressaThis drug has as active FDA Safety Alert (gefitinib)
IsotretinoinThis drug has as active FDA Safety Alert

back to top

J
Januvia (sitagliptin phosphate)

back to top

K
Kaletra (lopinavir; ritonavir)
Kepivance (palifermin)
KeppraThis drug has as active FDA Safety Alert (levetiracetam)
Ketek (telithromycin)
Ketotifen fumarate

back to top

L
LamictalThis drug has as active FDA Safety Alert (lamotrigine)
LamotrigineThis drug has as active FDA Safety Alert
Lantus (insulin glargine recombinant)
Leflunomide
Lenalidomide
Lepirudin recombinant
Levalbuterol
Levemir (insulin detemir recombinant)
LevetiracetamThis drug has as active FDA Safety Alert
Levitra (vardenafil)
Levonorgestrel
Levothyroxine sodium
Levulan Kerastick (aminolevulinic acid)
LexaproThis drug has as active FDA Safety Alert (escitalopram)
Lindane
LinezolidThis drug has as active FDA Safety Alert
LisinoprilThis drug has as active FDA Safety Alert
Lopinavir/ritonavir
Lotemax (loteprednol etabonate)
LotensinThis drug has as active FDA Safety Alert (benazepril)
Loteprednol etabonate
Lotronex (alosetron hydrochloride)
Lubiprostone
Lucentis (ranibizumab)
Lumigan (bimatoprost)
Lunestra (eszopiclone)
LyricaThis drug has as active FDA Safety Alert (pregabalin)

back to top

M
Macugen (pegaptanib)
MagnevistThis drug has as active FDA Safety Alert (gadopentetate dimeglumine)
Maraviroc
MavikThis drug has as active FDA Safety Alert (trandolapril)
MaxaltThis drug has as active FDA Safety Alert (rizatriptan benzoate)
MaxipimeThis drug has as active FDA Safety Alert (cefepime)
Mecasermin [rDNA origin]
Mecasermin-rinfabate
Meloxicam
Memantine
Metadate CD (methylphenidate HCl)
ylphenidate HCl)
Methylphenidate HCl
Methylphenidate transdermal
Mequinol
Micafungin
Micardis (telmisartan)
misartan)
MifeprexThis drug has as active FDA Safety Alert (mifepristone)
MifepristoneThis drug has as active FDA Safety Alert
Miglustat
MinirinThis drug has as active FDA Safety Alert (desmopressin)
MirtazapineThis drug has as active FDA Safety Alert
MisoprostolThis drug has as active FDA Safety Alert
Mobic (meloxicam)
Modafinil
MoexiprilThis drug has as active FDA Safety Alert
MonoprilThis drug has as active FDA Safety Alert (fosinopril)
Moxifloxacin
MultiHanceThis drug has as active FDA Safety Alert (gadobenate dimeglumine)
Mycamine (micafungin)
Mylotarg (gemtuzumab ozogamicin)

back to top

N
Namenda (memantine)
NaprosynThis drug has as active FDA Safety Alert (naproxen)
NaproxenThis drug has as active FDA Safety Alert
Naratriptan
Nesiritide recombinant
Nateglinide
Natrecor (nesiritide recombinant)
NefazodoneThis drug has as active FDA Safety Alert
Nelarabine
NeoTect Kit (technetium Tc 99m depreotide)
Nesiritide recombinant
NeurontinThis drug has as active FDA Safety Alert (gabapentin)
Nexavar (sorafenib)
Nitazoxanide
Nitisinone
Norelgestromin
NovoLog (insulin aspart recombinant)
Noxafil (posaconazole)

back to top

O
Olanzapine
Olanzapine/fluoxetineThis drug has as active FDA Safety Alert
Olmesartan medoxomil
Omacor (omega-3-acid ethyl esters)
OmalizumabThis drug has as active FDA Safety Alert
Omega-3-acid ethyl esters
Omnaris (cirlesonide)
OmniscanThis drug has as active FDA Safety Alert (gadodiamide)
OptiMARK (gadoversetamide)
Optison (perflutren protein-type A microspheres)
Orencia (abatacept)
Orfadin (nitisinone)
Orlistat
Ortho Evra (norelgestromin; ethinyl estradiol)
Oseltamivir phosphate
OsmoprepThis drug has as active FDA Safety Alert (sodium phosphate)
Oxaliplatin
OxcarbazepineThis drug has as active FDA Safety Alert


back to top

P
PaceroneThis drug has as active FDA Safety Alert (amiodarone)
Palifermin
Paliperidone
PamidronateThis drug has as active FDA Safety Alert
Panitumumab
Panretin Gel (alitretinoin)
Pantoprazole
Paricalcitol
ParoxetineThis drug has as active FDA Safety Alert
PaxilThis drug has as active FDA Safety Alert (paroxetine)
Pegaptanib
Pegvisomant
Pemetrexed
PemolineThis drug has as active FDA Safety Alert
Pentobarbital and carbromal
Perflutren lipid microspheres
PerindoprilThis drug has as active FDA Safety Alert
PhenerganThis drug has as active FDA Safety Alert (promethazine)
Pimecrolimus
PioglitazoneThis drug has as active FDA Safety Alert
Placidyl (ethchlorvynol)
Plan B (levonorgestrel)
Pletal (cilostazol)
Poractant alfa
Posaconazole
Pramlintide Acetate
Precedex (dexmedetomidine)
PregabalinThis drug has as active FDA Safety Alert
Prezista (darunavir)
Prialt (ziconotide)
Priftin (rifapentine)
PrinivilThis drug has as active FDA Safety Alert (lisinopril)
ProcritThis drug has as active FDA Safety Alert (epoetin alfa)
ProHanceThis drug has as active FDA Safety Alert (gadoteridol)
PromethazineThis drug has as active FDA Safety Alert
PropofolThis drug has as active FDA Safety Alert
Prosom (estazolam)
Protonix (pantoprazole)
Protopic (tacrolimus)
Provigil (modafinil)
ProzacThis drug has as active FDA Safety Alert (fluoxetine)
Prussian blue


back to top

 Q
Quazepam
Quetiapine
QuinaprilThis drug has as active FDA Safety Alert
Quinupristin

R
Rabeprazole
Radiogardase (prussian blue)
Ramelteon
RamiprilThis drug has as active FDA Safety Alert
Ranexa (ranolazine)
Ranibizumab
Ranolazine
Rapamune (sirolimus)
Raptiva (efalizumab)
Rasagiline